BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 38616245)

  • 1. The Impact of HIFU Ablation on the Histopathological Features of Locally Recurrent Fibroids Tissue Post-HIFU Treatment.
    Zhang P; Xie L; Chen J; Zhan P; Xing HR; Yuan Y
    Ultrasound Med Biol; 2024 Jun; ():. PubMed ID: 38897842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted MRI with deep learning for visualizing treatment results of MR-guided HIFU ablation of uterine fibroids.
    Slotman DJ; Bartels LW; Zijlstra A; Verpalen IM; van Osch JAC; Nijholt IM; Heijman E; van 't Veer-Ten Kate M; de Boer E; van den Hoed RD; Froeling M; Boomsma MF
    Eur Radiol; 2023 Jun; 33(6):4178-4188. PubMed ID: 36472702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids.
    Ikink ME; Voogt MJ; van den Bosch MA; Nijenhuis RJ; Keserci B; Kim YS; Vincken KL; Bartels LW
    Eur Radiol; 2014 Sep; 24(9):2118-27. PubMed ID: 24962829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue characterization of uterine fibroids with an intravoxel incoherent motion model: The need for T
    Qu F; Hor PH; Fischer J; Muthupillai R
    J Magn Reson Imaging; 2018 Oct; 48(4):994-1001. PubMed ID: 29504178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of MRI IVIM and MR perfusion imaging in acute ischemic stroke due to large vessel occlusion.
    Zhu G; Federau C; Wintermark M; Chen H; Marcellus DG; Martin BW; Heit JJ
    Int J Stroke; 2020 Apr; 15(3):332-342. PubMed ID: 31480940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravoxel incoherent motion diffusion-weighted MRI for predicting the efficacy of high-intensity focused ultrasound ablation for uterine fibroids.
    Jiang Y; Qin S; Wang Y; Liu Y; Liu N; Tang L; Fang J; Jia Q; Huang X
    Front Oncol; 2023; 13():1178649. PubMed ID: 37427113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravoxel incoherent motion (IVIM)-derived perfusion fraction mapping for the visual evaluation of MR-guided high intensity focused ultrasound (MR-HIFU) ablation of uterine fibroids.
    Slotman DJ; Bartels LW; Nijholt IM; Froeling M; Huirne JAF; Moonen CTW; Boomsma MF
    Int J Hyperthermia; 2024; 41(1):2321980. PubMed ID: 38616245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome and risk factors of reintervention after high intensity focused ultrasound ablation for uterine fibroids: a systematic review and meta-analysis.
    Dou Y; Zhang L; Liu Y; He M; Wang Y; Wang Z
    Int J Hyperthermia; 2024; 41(1):2299479. PubMed ID: 38164630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main Polish center and a review of current data.
    Łoziński T; Filipowska J; Gurynowicz G; Zgliczyńska M; Kluz T; Jędra R; Skowyra A; Ciebiera M
    Int J Hyperthermia; 2019; 36(1):582-590. PubMed ID: 31159642
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU): Technical Background and Overview of Current Clinical Applications (Part 1).
    Siedek F; Yeo SY; Heijman E; Grinstein O; Bratke G; Heneweer C; Puesken M; Persigehl T; Maintz D; Grüll H
    Rofo; 2019 Jun; 191(6):522-530. PubMed ID: 30630200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of reproductive outcomes after High Intensity Focused Ultrasound treatment of uterine fibroids.
    Anneveldt KJ; van 't Oever HJ; Nijholt IM; Dijkstra JR; Hehenkamp WJ; Veersema S; Huirne JAF; Schutte JM; Boomsma MF
    Eur J Radiol; 2021 Aug; 141():109801. PubMed ID: 34116454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Technical Aspects of MR-Guided High Intensity Focused Ultrasound for Treatment of Symptomatic Uterine Fibroids.
    Rueff LE; Raman SS
    Semin Intervent Radiol; 2013 Dec; 30(4):347-53. PubMed ID: 24436561
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.